These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32024682)

  • 1. A New Rho(d) Map to Diffuse Gastric Cancer.
    Benton D; Chernoff J
    Cancer Discov; 2020 Feb; 10(2):182-184. PubMed ID: 32024682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gain-of-Function
    Zhang H; Schaefer A; Wang Y; Hodge RG; Blake DR; Diehl JN; Papageorge AG; Stachler MD; Liao J; Zhou J; Wu Z; Akarca FG; de Klerk LK; Derks S; Pierobon M; Hoadley KA; Wang TC; Church G; Wong KK; Petricoin EF; Cox AD; Lowy DR; Der CJ; Bass AJ
    Cancer Discov; 2020 Feb; 10(2):288-305. PubMed ID: 31771969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RHOA
    Schaefer A; Hodge RG; Zhang H; Hobbs GA; Dilly J; Huynh MV; Goodwin CM; Zhang F; Diehl JN; Pierobon M; Baldelli E; Javaid S; Guthrie K; Rashid NU; Petricoin EF; Cox AD; Hahn WC; Aguirre AJ; Bass AJ; Der CJ
    Sci Signal; 2023 Dec; 16(816):eadg5289. PubMed ID: 38113333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sporadic Early-Onset Diffuse Gastric Cancers Have High Frequency of Somatic CDH1 Alterations, but Low Frequency of Somatic RHOA Mutations Compared With Late-Onset Cancers.
    Cho SY; Park JW; Liu Y; Park YS; Kim JH; Yang H; Um H; Ko WR; Lee BI; Kwon SY; Ryu SW; Kwon CH; Park DY; Lee JH; Lee SI; Song KS; Hur H; Han SU; Chang H; Kim SJ; Kim BS; Yook JH; Yoo MW; Kim BS; Lee IS; Kook MC; Thiessen N; He A; Stewart C; Dunford A; Kim J; Shih J; Saksena G; Cherniack AD; Schumacher S; Weiner AT; Rosenberg M; Getz G; Yang EG; Ryu MH; Bass AJ; Kim HK
    Gastroenterology; 2017 Aug; 153(2):536-549.e26. PubMed ID: 28522256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic tumour suppressor activity of E-cadherin and p53 in a conditional mouse model for metastatic diffuse-type gastric cancer.
    Shimada S; Mimata A; Sekine M; Mogushi K; Akiyama Y; Fukamachi H; Jonkers J; Tanaka H; Eishi Y; Yuasa Y
    Gut; 2012 Mar; 61(3):344-53. PubMed ID: 21865403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a recurrent germ line mutation of the E-cadherin gene: implications for genetic testing and clinical management.
    Suriano G; Yew S; Ferreira P; Senz J; Kaurah P; Ford JM; Longacre TA; Norton JA; Chun N; Young S; Oliveira MJ; Macgillivray B; Rao A; Sears D; Jackson CE; Boyd J; Yee C; Deters C; Pai GS; Hammond LS; McGivern BJ; Medgyesy D; Sartz D; Arun B; Oelschlager BK; Upton MP; Neufeld-Kaiser W; Silva OE; Donenberg TR; Kooby DA; Sharma S; Jonsson BA; Gronberg H; Gallinger S; Seruca R; Lynch H; Huntsman DG
    Clin Cancer Res; 2005 Aug; 11(15):5401-9. PubMed ID: 16061854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo effects of mutant RHOA on tumor formation in an orthotopic inoculation model.
    Nishizawa T; Nakano K; Fujii E; Komura D; Kuroiwa Y; Ishimaru C; Monnai M; Aburatani H; Ishikawa S; Suzuki M
    Oncol Rep; 2019 Nov; 42(5):1745-1754. PubMed ID: 31485674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RHOA drivers take alternate routes in gastric cancer.
    Benton D; Chernoff J
    Sci Signal; 2023 Dec; 16(816):eadk9171. PubMed ID: 38113334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDH1 somatic alterations in Mexican patients with diffuse and mixed sporadic gastric cancer.
    Bustos-Carpinteyro AR; Oliveira C; Sousa A; Oliveira P; Pinheiro H; Carvalho J; Magaña-Torres MT; Flores-Miramontes MG; Aguilar-Lemarroy A; Jave-Suárez LF; Peregrina-Sandoval J; Cruz-Ramos JA; Sánchez-López JY
    BMC Cancer; 2019 Jan; 19(1):69. PubMed ID: 30642281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria.
    Brooks-Wilson AR; Kaurah P; Suriano G; Leach S; Senz J; Grehan N; Butterfield YS; Jeyes J; Schinas J; Bacani J; Kelsey M; Ferreira P; MacGillivray B; MacLeod P; Micek M; Ford J; Foulkes W; Australie K; Greenberg C; LaPointe M; Gilpin C; Nikkel S; Gilchrist D; Hughes R; Jackson CE; Monaghan KG; Oliveira MJ; Seruca R; Gallinger S; Caldas C; Huntsman D
    J Med Genet; 2004 Jul; 41(7):508-17. PubMed ID: 15235021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
    van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
    Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant alternative splicing of RHOA is associated with loss of its expression and activity in diffuse-type gastric carcinoma cells.
    Miyamoto S; Nagamura Y; Nakabo A; Okabe A; Yanagihara K; Fukami K; Sakai R; Yamaguchi H
    Biochem Biophys Res Commun; 2018 Jan; 495(2):1942-1947. PubMed ID: 29247652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-omics analysis identifies pathways and genes involved in diffuse-type gastric carcinogenesis induced by E-cadherin, p53, and Smad4 loss in mice.
    Park JW; Kim MS; Voon DC; Kim SJ; Bae J; Mun DG; Ko SI; Kim HK; Lee SW; Kim DY
    Mol Carcinog; 2018 Jul; 57(7):947-954. PubMed ID: 29528141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E-cadherin is a biomarker for ferroptosis sensitivity in diffuse gastric cancer.
    Minikes AM; Song Y; Feng Y; Yoon C; Yoon SS; Jiang X
    Oncogene; 2023 Mar; 42(11):848-857. PubMed ID: 36717701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma.
    Kakiuchi M; Nishizawa T; Ueda H; Gotoh K; Tanaka A; Hayashi A; Yamamoto S; Tatsuno K; Katoh H; Watanabe Y; Ichimura T; Ushiku T; Funahashi S; Tateishi K; Wada I; Shimizu N; Nomura S; Koike K; Seto Y; Fukayama M; Aburatani H; Ishikawa S
    Nat Genet; 2014 Jun; 46(6):583-7. PubMed ID: 24816255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Destabilized adhesion in the gastric proliferative zone and c-Src kinase activation mark the development of early diffuse gastric cancer.
    Humar B; Fukuzawa R; Blair V; Dunbier A; More H; Charlton A; Yang HK; Kim WH; Reeve AE; Martin I; Guilford P
    Cancer Res; 2007 Mar; 67(6):2480-9. PubMed ID: 17363565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell division-dependent dissemination following E-cadherin loss underlies initiation of diffuse-type gastric cancer.
    Monster JL; Kemp LJ; Busslinger GA; Vliem MJ; Derks LL; Staes AA; Bisseling TM; Clevers H; van der Post RS; Gloerich M
    J Pathol; 2024 Jun; 263(2):226-241. PubMed ID: 38572612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the Functional Impact of CDH1 Missense Mutations in Hereditary Diffuse Gastric Cancer.
    Melo S; Figueiredo J; Fernandes MS; Gonçalves M; Morais-de-Sá E; Sanches JM; Seruca R
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29231860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study.
    Benusiglio PR; Malka D; Rouleau E; De Pauw A; Buecher B; Noguès C; Fourme E; Colas C; Coulet F; Warcoin M; Grandjouan S; Sezeur A; Laurent-Puig P; Molière D; Tlemsani C; Di Maria M; Byrde V; Delaloge S; Blayau M; Caron O
    J Med Genet; 2013 Jul; 50(7):486-9. PubMed ID: 23709761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffuse Gastric Cancer: A Comprehensive Review of Molecular Features and Emerging Therapeutics.
    Wu LW; Jang SJ; Shapiro C; Fazlollahi L; Wang TC; Ryeom SW; Moy RH
    Target Oncol; 2024 Nov; 19(6):845-865. PubMed ID: 39271577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.